Neurovascular Orofacial Pain
Orofacial Migraine
Migraine frequently presents with orofacial pain as a primary complaint — pain in the temple, jaw, periorbital region, or maxilla that leads patients to seek dental or TMJ evaluation rather than neurological assessment. Classifying the neurovascular cause distinguishes orofacial migraine from TMD and prevents misdirected treatment.
Symptom Profile
The Orofacial Migraine Presentation
- Unilateral, pulsating or throbbing pain in the temple, periorbital region, maxilla, or mandible — often misattributed to dental or TMJ origin
- Moderate to severe intensity with exacerbation by routine physical activity or head movement
- Duration of 4 to 72 hours (untreated), distinguishing migraine from shorter paroxysmal neuralgiform conditions
- Associated symptoms: nausea, photophobia, phonophobia, osmophobia, or aura (visual disturbances, sensory changes)
- Referred pain patterns into the masseter, temporalis, and cervical musculature that mimic myofascial pain
- Allodynia of the scalp, face, or periorbital region during attacks — a marker of central sensitization
- Trigger identification: hormonal fluctuations, sleep disruption, dietary factors, weather changes, or stress
The overlap between migraine and TMD symptom presentations is substantial. Both conditions can produce pain in the temple, masseter, and periorbital regions. Both can be associated with restricted jaw opening during severe attacks. The distinguishing factors are the neurological characteristics of migraine — the pulsating quality, associated autonomic features, and photophobia/phonophobia — which map to a neurovascular cause rather than a musculoskeletal one.
Pathophysiology
The Neurovascular Mechanism
Migraine is a neurovascular disorder involving cortical spreading depression, activation of the trigeminovascular system, and release of calcitonin gene-related peptide (CGRP) and other neuropeptides that produce neurogenic inflammation and vasodilation of meningeal and cerebral vessels. The trigeminal nerve innervates the meninges, face, jaw, and oral cavity — which is why migraine pain is experienced in orofacial structures.
In orofacial migraine, the pain distribution follows the trigeminal nerve's ophthalmic (V1) and maxillary (V2) divisions with referral into the mandibular (V3) territory. This produces pain in the temple, periorbital area, maxilla, and preauricular region — locations that overlap with TMD, dental pathology, and sinus disease. The central sensitization that develops with chronic migraine amplifies pain in these referral zones, making the clinical picture more complex.
Key Neurovascular Features
- Cortical spreading depression — a wave of neuronal depolarization that precedes migraine aura and activates the trigeminovascular system
- Trigeminovascular activation — stimulation of trigeminal nerve fibers innervating the meninges and cerebral vasculature
- CGRP release — a potent vasodilator and neuropeptide that drives neurogenic inflammation and pain signaling
- Central sensitization — amplified pain processing that causes secondary hyperalgesia in the orofacial region
Migraine vs. TMD: Why the Distinction Matters
- Migraine is treated with triptans, CGRP antagonists, and preventive neurovascular medications — not occlusal splints
- TMD treatment (physical therapy, joint injection) will not resolve migraine, and vice versa
- Migraine and TMD are frequently comorbid — both may be present, but the dominant cause must be identified to prioritize treatment
- The presence of neurological features (aura, photophobia, nausea) shifts the classification toward neurovascular etiology
Diagnostic Taxonomy
ICHD-3 Classification: Migraine with Orofacial Involvement
The International Classification of Headache Disorders, 3rd edition (ICHD-3), published by the International Headache Society, provides the standardized diagnostic framework for migraine classification. Orofacial pain attributed to migraine falls within this taxonomy, and the ICHD-3 criteria must be applied before a neurovascular diagnosis is confirmed.
1. Migraine Without Aura (ICHD-3 1.1)
Recurrent headache attacks lasting 4–72 hours, unilateral, pulsating quality, moderate to severe intensity, aggravated by physical activity, with nausea and/or photophobia and phonophobia. When the pain distribution involves the temple, maxilla, or mandible, this is the most common orofacial migraine presentation.
2. Migraine With Aura (ICHD-3 1.2)
Migraine attacks preceded by reversible focal neurological symptoms — most commonly visual (scintillating scotoma, fortification spectra). Aura symptoms develop gradually over 5 minutes and last 5–60 minutes. Orofacial pain follows the aura phase in the same distribution.
3. Chronic Migraine (ICHD-3 1.3)
Headache occurring on 15 or more days per month for more than three months, with at least eight of those days meeting migraine criteria. Chronic migraine often presents with continuous or near-continuous orofacial pain and is associated with medication overuse and central sensitization.
4. Probable Migraine (ICHD-3 1.6)
Headache attacks that meet all but one of the criteria for migraine without aura. Commonly encountered in orofacial presentations where patients describe the characteristic features but the clinical picture is incomplete — requiring careful classification and monitoring for evolution to definite migraine.
5. Headache Attributed to TMD (ICHD-3 11.7)
Headache caused by a disorder of the temporomandibular joint or masticatory muscles, with evidence of causation demonstrated by clinical examination and imaging. This diagnostic code exists specifically for the migraine-TMD overlap — it classifies headache that is genuinely TMD-attributed rather than migraine-referred.
Clinical Protocol
Diagnostic Approach
Systematic application of ICHD-3 diagnostic criteria — pain character, location, duration, frequency, associated symptoms (nausea, photophobia, phonophobia), aura, trigger patterns, and disability impact. Complete headache diary review with validated screening instruments.
Comprehensive examination of the TMJ (range of motion, joint sounds, palpation), masticatory muscles (trigger points, tenderness patterns), cervical spine, and cranial nerve assessment. Mapping of pain referral patterns to differentiate neurovascular from musculoskeletal sources.
Integration of headache criteria with orofacial examination findings to determine the primary root cause. Differentiation of: (a) migraine with orofacial involvement, (b) TMD with headache, (c) tension-type headache with craniofacial referral, and (d) overlapping migraine-TMD presentations with dual pathology.
Treatment protocol matched to the confirmed classification. Neurovascular treatment (triptans, CGRP-targeted therapies, preventive medications) for migraine-attributed orofacial pain. Musculoskeletal treatment (physical therapy, myofunctional therapy, joint-specific interventions) for TMD-attributed headache. Combined approach when dual pathology is confirmed.
If your orofacial pain has been treated as a dental or TMJ condition without resolution, and you experience pulsating head or facial pain with light sensitivity, sound sensitivity, or nausea, a neurovascular classification should be considered.
Return to Symptom Triage